Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD

Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More